Search clinical trials for: Molecular study (Polymerase chain reaction)
Total 95158 results
-
AstraZenecaCompleted
-
Tianjin Medical University Cancer Institute and...RecruitingExtensive-stage Small Cell Lung CancerChina
-
Erasmus Medical CenterRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide TherapyNetherlands
-
Ruijin HospitalNot yet recruiting
-
Sichuan Cancer Hospital and Research InstituteNot yet recruiting
-
Wuhan UniversityNot yet recruitingRecurrent Small Cell Lung Cancer
-
AstraZenecaMerck Sharp & Dohme LLC; NRG Oncology; Breast International Group; Myriad Genetic... and other collaboratorsActive, not recruitingBreast CancerUnited States, Austria, Italy, Spain, Sweden, United Kingdom, Belgium, Poland, France, Switzerland, Canada, Germany, Korea, Republic of, Netherlands, Japan, China, Taiwan, Australia, Argentina, Israel, Hungary, Portugal, Iceland, Puerto...
-
University College, LondonAstraZeneca; Cancer Research UKActive, not recruitingHead and Neck CancerUnited Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, China, Spain, Japan, United Kingdom
-
PfizerCompletedBreast CancerUnited States
-
The University of Hong KongCompletedOvarian CancerHong Kong
-
Dantari, Inc.CompletedHER2-negative Metastatic Breast CancerUnited States
-
Janssen Research & Development, LLCActive, not recruitingProstatic NeoplasmsUnited States, Australia, France, United Kingdom, Belgium, Taiwan, Spain, Israel, Netherlands, Sweden, Korea, Republic of, Canada, Russian Federation, Brazil, Denmark
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
PfizerMedivation, Inc.CompletedCancerUnited States, Canada, United Kingdom, France, Poland, Hungary, Germany, Moldova, Republic of, Russian Federation
-
TakedaCompletedAdvanced Solid TumorsJapan
-
AstraZenecaCompletedLymphoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Malignant Solid TumorsUnited States, Canada
-
Istituto Scientifico Romagnolo per lo Studio e...UnknownNeoplasms, Germ Cell and EmbryonalItaly
-
Peking University Cancer Hospital & InstituteUnknownPancreatic Cancer | Gastric Adenocarcinoma | Cholangiocarcinoma | HER2-negative Breast CancerChina
-
Hunan Cancer HospitalUnknown
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
Istituti Ospitalieri di CremonaUnknownBreast Cancer | Triple Negative Breast Cancer
-
Tesaro, Inc.CompletedChronic Lymphocytic Leukemia | Solid Tumors | T-cell-prolymphocytic Leukemia
-
University College, LondonAstraZenecaWithdrawn
-
German Breast GroupGlaxoSmithKline; Stemline Therapeutics, Inc.Not yet recruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | Hormone Receptor Positive HER-2 Negative Breast Cancer | Advanced or Metastatic Breast CancerGermany
-
National Taiwan University HospitalAstraZenecaRecruiting
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingOvarian Cancer | Fallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France
-
Sun Yat-sen UniversityRecruitingNasopharyngeal CarcinomaChina
-
Gruppo Oncologico del Nord-OvestRecruitingHead and Neck Squamous Cell CarcinomaItaly
-
National Cancer Institute, NaplesRecruitingBRCA Wild Type Platinum Sensitive Recurrent Ovarian CancerItaly
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
National Cancer Institute (NCI)RecruitingLung Neoplasms | Small Cell Lung Cancer | Prostate Cancer | Urothelial Carcinoma | Urothelial CancerUnited States
-
Tango Therapeutics, Inc.TerminatedBreast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | BRCA1 Mutation | BRCA-Mutated Ovarian Carcinoma | BRCA-Associated Breast Carcinoma | HRD Positive Advanced Ovarian CancerUnited States
-
BayerGlaxoSmithKlineTerminatedOvarian Cancer | Advanced Solid Tumors (Excluding Prostate Cancer)United States
-
Sheba Medical CenterCompleted
-
Institut BergoniéNational Cancer Institute, FranceCompleted
-
PfizerMedivation, Inc.Completed
-
AstraZenecaParexelApproved for marketing
-
Roswell Park Cancer InstituteAstraZenecaActive, not recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Serous AdenocarcinomaUnited States
-
Boehringer IngelheimCompletedLung Diseases, InterstitialUnited States, Spain, Belgium, Canada, Korea, Republic of, Germany, United Kingdom, Japan, China, France, Italy, Chile, Poland, Russian Federation, Argentina
-
University of WashingtonAstraZenecaActive, not recruitingBiochemically Recurrent Prostate Carcinoma | Prostate AdenocarcinomaUnited States
-
Weill Medical College of Cornell UniversityBoehringer IngelheimCompleted
-
Massachusetts General HospitalGlaxoSmithKlineRecruitingMetastatic Cancer | Central Nervous System CancerUnited States
-
AstraZenecaActive, not recruitingBreast | Prostate | Ovarian | Pancreatic | Advanced TumoursSweden, Spain, Israel, Australia, Germany
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Haihe Biopharma Co., Ltd.TerminatedBreast Cancer | Ovarian Cancer | Solid Tumor | Prostate Cancer | Endometrial CancerUnited States, Australia, China
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate AdenocarcinomaUnited States
-
GlaxoSmithKlineSuspendedNeoplasmsGermany, Spain, United Kingdom, France, Hungary, Czechia
-
Sarah E TaylorAmerican Society of Clinical OncologyTerminatedOvarian CancerUnited States
-
Arcagy ResearchBelgian Gynaecological Oncology Group; Grupo Español de Investigación en Cáncer... and other collaboratorsCompletedOvarian CancerFrance, Germany, Austria, Denmark, Italy, Japan, Finland, Spain, Monaco, Sweden, Belgium